Growth hormone (GH), insulin-like growth factors (IGFs), and IGF-binding protein-3 (IGFBP-3) in a child with Proteus syndrome. 1994

G Rudolph, and W F Blum, and E W Jenne, and M Schöning, and H Enders, and T Meitinger, and J D Murken, and A Kampik
Augenklinik Universität München, Germany.

Proteus syndrome is a congenital hamartomatous disorder characterized by partial overgrowth involving all germ layers. A somatic mutation model has been proposed since familial cases are extremely rare. We report on a 3-year-old girl with typical manifestations of Proteus syndrome, including local, asymmetric hypertrophy of various parts of the body. Total body length was reduced. Serum levels of IGF-I and especially IGF-II and their major growth hormone dependent binding protein (IGFBP-3) were significantly reduced, although growth hormone secretion after a pharmacological stimulus was normal. In vitro studies of fibroblasts derived from hypertrophied tissue showed normal IGF-I production and somewhat reduced IGF-II and IGFBP-3 production as compared to normal human skin fibroblasts. Affinity cross-linking experiments showed that fibroblasts of the affect tissue in Proteus syndrome produced an unusual pattern of IGF bindings proteins containing large amounts of an IGFBP with high affinity to IGF-II. The data suggest that IGF production is generally disturbed in Proteus syndrome with imbalanced levels of specific IGFBP in affected tissue.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D007335 Insulin-Like Growth Factor II A well-characterized neutral peptide believed to be secreted by the LIVER and to circulate in the BLOOD. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults. IGF-II,Multiplication-Stimulating Activity,Somatomedin MSA,IGF-2,Insulin Like Growth Factor II,Insulin-Like Somatomedin Peptide II,Multiplication-Stimulating Factor,Somatomedin A,Factor, Multiplication-Stimulating,Insulin Like Somatomedin Peptide II,Multiplication Stimulating Activity,Multiplication Stimulating Factor
D008297 Male Males
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D005260 Female Females

Related Publications

G Rudolph, and W F Blum, and E W Jenne, and M Schöning, and H Enders, and T Meitinger, and J D Murken, and A Kampik
February 1997, Journal of Korean medical science,
G Rudolph, and W F Blum, and E W Jenne, and M Schöning, and H Enders, and T Meitinger, and J D Murken, and A Kampik
December 2011, Growth factors (Chur, Switzerland),
G Rudolph, and W F Blum, and E W Jenne, and M Schöning, and H Enders, and T Meitinger, and J D Murken, and A Kampik
January 1999, Hormone research,
G Rudolph, and W F Blum, and E W Jenne, and M Schöning, and H Enders, and T Meitinger, and J D Murken, and A Kampik
February 1994, Biochemical and biophysical research communications,
G Rudolph, and W F Blum, and E W Jenne, and M Schöning, and H Enders, and T Meitinger, and J D Murken, and A Kampik
February 1992, Endocrinology,
G Rudolph, and W F Blum, and E W Jenne, and M Schöning, and H Enders, and T Meitinger, and J D Murken, and A Kampik
June 1996, The Journal of clinical endocrinology and metabolism,
G Rudolph, and W F Blum, and E W Jenne, and M Schöning, and H Enders, and T Meitinger, and J D Murken, and A Kampik
January 2005, Acta physiologica Hungarica,
G Rudolph, and W F Blum, and E W Jenne, and M Schöning, and H Enders, and T Meitinger, and J D Murken, and A Kampik
March 1993, The Journal of endocrinology,
G Rudolph, and W F Blum, and E W Jenne, and M Schöning, and H Enders, and T Meitinger, and J D Murken, and A Kampik
December 1998, Metabolism: clinical and experimental,
G Rudolph, and W F Blum, and E W Jenne, and M Schöning, and H Enders, and T Meitinger, and J D Murken, and A Kampik
July 1993, Domestic animal endocrinology,
Copied contents to your clipboard!